Evidence map›Paper›PMID 38245746›Full record

ArticleMicrobial cell factories2024

Highly selective whole-cell 25-hydroxyvitamin D

Dennis Kosian, Max Willistein, Ralf Weßbecher, Constantin Eggers, Oliver May, Matthias Boll

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial cell factories, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Selective Oxidation of Vitamin DChemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Dennis Kosian *Faculty of Biology - Microbiology, University of Freiburg, 79104, Freiburg, Germany.
Max Willistein *Faculty of Biology - Microbiology, University of Freiburg, 79104, Freiburg, Germany.
Ralf WeßbecherFaculty of Biology - Microbiology, University of Freiburg, 79104, Freiburg, Germany.
Constantin EggersFaculty of Biology - Microbiology, University of Freiburg, 79104, Freiburg, Germany.
Oliver MayDSM Nutritional Products, Koninklijke DSM N.V., Kaiseraugst, 4303, Switzerland.
Matthias BollFaculty of Biology - Microbiology, University of Freiburg, 79104, Freiburg, Germany. matthias.boll@biologie.uni-freiburg.de.
University of Freiburg · DEDSM (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global prevalence of vitamin D (VitD) deficiency associated with numerous acute and chronic diseases has led to strategies to improve the VitD status through dietary intake of VitD-fortified foods and VitD supplementation. In this context, the circulating form of VitD

resultsIn this study, we used a whole-cell approach for biocatalytic 25OHVitD

conclusionsThe established steroid C25 dehydrogenase-based whole-cell system for the value-adding conversion of VitD

Indexed as

CyclodextrinsVitamin D DeficiencyCalcifediolCholecalciferolHumansMolybdenumSteroidsVitamin DVitamins25-hydroxyvitamin DCalcifediolCholecalciferolCyclodextrinsMolybdenumSteroidsVitamin DVitamins25-hydroxyvitamin D3CalcifediolCalcitriolCyclodextrinMolybdenum-dependent hydroxylaseSteroid C25 hydroxylaseThauera aromaticaVitamin D3Whole-cell biocatalysis

Identifiers

PMID38245746
PMCPMC10799449
OpenAlexW4391053507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.